Dr. Nebojsa "Nash" Petrovic
Known professionally as "Nash," Dr. Petrovic has been specializing in Chronic Fatigue Syndrome (CFS) and related disorders for over 30 years.
He earned his medical degree at [University Name] and completed advanced training in [specialty]. Dr. Petrovic's approach is guided by evidence-based research and supported by independent evaluations by Prof. Dr. T.A. Kilroe-Smith, PhD, a medical biochemist and former director of the South African National Institute for Occupational Health.
Dr. Petrovic has worked with and supported patients internationally, with many reporting significant improvement in their health and quality of life. His work in this field was referenced in the international bestseller Explaining Unexplained Illnesses by Prof. Dr. Martin Pall of Washington State University. His patients and colleagues often refer to him as "Nash," reflecting his approachable, patient-centered style.
1961
Born in Yugoslavia
1976
Working in the High School Department of Human Genetics & Biology, noted that laboratory animals displayed greater resistance to oxidative and other stressors when previously supplied with antioxidant vitamins.
Studied Dr Hayflick's research work regarding the influence of tocopherols on in vitro human cells, which caused an increase in life span which did not correspond to so-called biological clock limits.
Self experimenting using various antioxidants and micronutrients.
Began collecting all available technological data relating to antioxidants for human consumption. His father, (Director of technology for a company specializing in enriching and preserving food products using vitamins and antioxidants and a winner of several European Awards for innovations in technology), provided the young Petrovic with access to international industrial information on antioxidants emanating from Japan, USA and Europe)
1981
Enrolled at Medical University of Belgrade
1982
Appointed principal student demonstrator/assistant at the Department of Histology & Biology
(Human Genetics). Enjoyed full access to university research material related to the specific
role played by antioxidants in biological systems.
1983
In addition to lecturing at the Medical University/ Department of Clinical Nutrition, started to explore the possible role of vitamins and antioxidants in the prevention of heart disease.
1983-89
Continued research in this field within various Departments on behalf of the Department of Internal Medicine. Findings of this study inferred that antioxidants produce optimal effects when taken together according to synergistic principles, and indicated that certain antioxidants could possibly reverse heart disease through prevention of cholesterol oxidation and activation of LCAT enzyme.
1989
Graduated cum laude as a Medical Doctor (M.D.) from the Medical University of Belgrade on 29 January 1989, with an honors degree and an overall average mark of 9.03.
1990
On 26 September 1990, presented an original free radical-based concept of arteriosclerosis, autoimmune disorders, and myalgic encephalomyelitis (ME), together with a novel synergistic antioxidant therapeutic platform for the potential regression of those diseases, to a panel of academic medical professors and World Health Organization (WHO) experts during the official State Examination for Medical Experts.
Received official commendation for this work and was formally classified as "best in class", achieving an unprecedented honor mark of 10+ (10 plus)-a distinction awarded for exceptional academic and scientific merit.
1990-1991
Completed residency training at the City Hospital and City Health Center in Pozarevac, gaining extensive experience in internal medicine and clinical research.
1991
Continued researching antioxidants and vitamins while working in a private practice which included hundreds of heart patients.
Carried out an independent study on the effects of antioxidants and related components on heat disease symptoms such as high blood pressure and angina pectoris. Presented these results to Prof Dr Med Simic, World Health Organization expert on nutrition, as well as to individual medical professors.
1992
Continued independent research in Greece, Germany and a few other European countries collecting all available data pertaining to antioxidants
Arrived in South Africa in 1992 to continue research into heart disease(RSA has one of the highest incidences of heart disease in the world)
1993-4
Continued research in antioxidant micronutrients and synergistic combinations of antioxidants. Presented his theories to Professor W J Serfontein, ,Professor Emeritus, Department of Chemical Pathology, University of Pretoria who responded (April 1993):
"I think that Dr Petrovic's proposal should receive serious attention."
1994
Administered a program of non-prescriptive, non-scheduled antioxidants and micronutrients to a previously diagnosed CFIDS sufferer of 10 years who reported significant symptom improvement within four days.
Continued working with CFIDS patients, obtaining highly encouraging results.
1995
Started with activities on the international scene and started treating patients outside RSA.
1995/6
Received congratulations for his work by all three associates of the double Nobel Prize Winner Dr Linus Pauling, Dr Mathias Rath (USA),Dr Brian Leibovitz (USA), Dr Richard Passwater (USA)
In 1996 His work becomes independently scrutinized by Dr Kilroe Smith, a medical biochemist and a former director of the RSA Institute for Occupational Health, who published more than 80 papers in prestigious international medical journals. In 1998, Dr Kilroe-Smith described Dr Petrovic's CFIDS Protocol as achieving highly successful therapeutic outcomes for CFIDS patients./1998 RSA Study/International Study Report/
1996-99
Continued research in the CFIDS field and coordinating international activities of his info CFIDS centers /patients' associations in the UK ,USA and Australia
2000-2014
Conducting intensive research in both CFIDS and secondary
superimposed autoimmune entities and/or entities with autoimmune component that very
frequently develop in CFIDS patients and that typically include:
-Chron's disease
-Lupus Erythematosus
-Ulcerative Colitis
-Rheumatoid Arthritis
-Asthma
In initial pilot studies all patients suffering from CFIDS and Chron's disease reported full
recovery on the CFIDS Protocol. Full clinical improvement of Crohn's disease was reported and documented through independent medical assessments, including histological examinations performed in Australia and South Africa.
All randomly selected patients participating in those studies reported substantial recovery and clinical improvement.
His research on the immunomodulatory properties of antioxidants and micronutrients has influenced later approaches to CFIDS management internationally and was cited by Prof. Dr. Martin Pall (Explaining Unexplained Illnesses, Washington State University).
Disclaimer:
This website is maintained for historical and reference purposes only.
The Petrovic CFIDS Health Center has permanently closed its physical premises.
All information is presented for educational and research reference, not for clinical use or medical diagnosis.
|
